A vendor-neutral guide for MedTech teams.
MedTechCyberTips.com is an organized, structured collection of practical guidance for medical device cybersecurity. It distills the most actionable tips across nine domains (overview, why it matters, SPDF, threat modeling, pentesting, premarket, FDA response, postmarket, and continuous monitoring) into one walk-through experience.
The goal: meet your team where you are, regardless of stage, and help you find the right next step.
Content is informed by Blue Goat Cyber's published guides on FDA submissions, premarket and postmarket cybersecurity, SPDF, threat modeling, penetration testing, and the GoatWatch monitoring service.
Visit Blue Goat CyberSources
Each topic on this site is informed by the corresponding canonical service or guide page on bluegoatcyber.com.
- Overview : Start here. The big picture for MedTech security.
- Why It Matters : The case for taking cybersecurity seriously: patients, brand, and revenue.
- SPDF : Bake security into every stage of the device lifecycle.
- Threat Modeling : Identify and reason about threats before they ship.
- Pentesting : What's in scope (hardware, firmware, wireless, cloud, mobile), the methods reviewers expect, and how to read a pentest report against FDA cybersecurity guidance.
- Premarket : Submit a cybersecurity package the FDA will accept.
- FDA Response : Turn an FDA cybersecurity hold into a clean clearance.
- Postmarket : Stay compliant and secure after your device is on the market.
- Monitoring : Continuous vulnerability monitoring for fielded devices.
- AI/ML Devices : Adversarial ML, model integrity, PCCPs, and the security surface unique to learning-enabled devices.
- Vuln Management : The end-to-end lifecycle: discovery, CVSS/rubric assessment, coordinated disclosure (CVD), and patch validation for fielded medical devices.
How this content is written and reviewed
The MedTech Cyber Tips editorial team is a group of practitioners with hands-on experience across FDA premarket cybersecurity submissions, Secure Product Development Framework (SPDF) implementation, medical device threat modeling, and postmarket vulnerability management. Every article, checklist, and update on this site is reviewed for accuracy against the FDA's February 3, 2026 final premarket cybersecurity guidance, Section 524B of the FD&C Act, MDCG 2019-16 Rev.2, IEC 81001-5-1, ISO 14971, and the EU Cyber Resilience Act. The team also tracks 510(k) deficiency patterns and CVE trends affecting connected medical devices so guidance on the site stays current.
View full profile →- Primary sources. Every regulatory claim is checked against the FDA's February 3 2026 final premarket cybersecurity guidance, Section 524B of the FD&C Act, MDCG 2019-16 Rev.2, IEC 81001-5-1, AAMI TIR57/SW96, and Regulation (EU) 2024/2847 (CRA).
- Independence. Sponsorship is disclosed on every page. Editorial content is not gated to, or produced by, the sponsor's marketing.
- Not legal advice. Guidance here informs decisions but does not replace regulatory counsel or a notified body.
How a page gets from draft to published
- 1
Scope & source pull. An editor identifies the regulatory or technical question, pulls the primary sources (FDA guidance, EU regulation, IEC/AAMI standard, CISA advisory), and drafts an outline.
- 2
Draft. Content is written in plain language, with every claim traceable to a cited source. Marketing terms are stripped; only the specific control, artifact, or expectation is described.
- 3
Technical review. A named reviewer with practitioner experience (submissions, threat modeling, or postmarket operations) checks the draft against real-world submissions and audit patterns.
- 4
Publish & date. The page ships with a byline, a visible last-reviewed date, and canonical citations. It's added to the sitemap and RSS.
- 5
Monitor. Regulatory changes, standards revisions, and reader-submitted corrections trigger targeted re-review outside the scheduled cadence.
When content is re-checked
Current site-wide review date: July 2026. Each surface has its own cadence:
| Surface | Cadence | Trigger for out-of-cycle review |
|---|---|---|
| Topic pages & walkthroughs | Every 90 days | New FDA guidance, standard revision, or notified-body pattern change |
| Compare (FDA / MDR / CRA) | Every 60 days | CRA delegated act, MDCG revision, 524B guidance amendment |
| Resources (checklists, templates) | Every 90 days | Referenced form or artifact expectation changes |
| Updates feed | Published entries are dated and not silently rewritten | Material correction adds a new dated update |
| Glossary | Every 180 days | Definition drift in a cited standard |
How we handle errors
- Typos and formatting. Fixed silently without changing the last-reviewed date.
- Clarifications. Reworded in place; last-reviewed date bumped if the meaning changed.
- Substantive corrections (wrong regulation cited, incorrect deadline, misstated requirement). Corrected inline with a dated "Correction:" note on the affected page and, when material, a new entry in the Updates feed.
- Retractions. If a page is materially wrong and cannot be fixed, it is retracted with a visible notice explaining why. The URL is preserved so external links don't rot.
- Attribution. Corrections submitted by named readers are credited on request.
Spot something wrong or out of date?
We treat corrections as first-class content changes. Include the page, the specific claim, and a source if you have one. Substantive fixes are noted inline on the affected page and, when material, in the Updates feed.
We aim to acknowledge corrections within 3 business days and resolve verified issues within 10 business days.
This site is educational. It is not legal or regulatory advice. Always consult qualified counsel and your regulatory team for submission decisions.